Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Sell
930
-27
-3% -$9.24K 0.2% 87
2026
Q1
$337K Sell
957
-22
-2% -$7.84K 0.24% 81
2025
Q4
$320K Sell
979
-19
-2% -$6.03K 0.23% 79
2025
Q3
$282K Buy
+998
New +$289K 0.21% 82
2025
Q1
$344K Buy
1,104
+14
+1% +$4.13K 0.3% 78
2024
Q4
$284K Sell
1,090
-13
-1% -$3.86K 0.25% 80
2024
Q3
$352K Buy
+1,103
New +$361K 0.29% 76

Other funds holding AMGN

Shum Financial Group's AMGN Position: Q2 2026 in Review

Shum Financial Group reduced its Amgen (AMGN) stake by 2.8% in Q2 2026, selling an estimated $9.24K and leaving 930 shares worth $337K. The position accounts for 0.2% of the portfolio, ranked #87.

Shum Financial Group first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $352K in Q3 2024. 1,943 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Shum Financial Group held 930 shares of Amgen worth $337K as of Q2 2026.
  • Shum Financial Group sold 27 Amgen shares in Q2 2026, an estimated $9.24K.
  • Amgen made up 0.2% of Shum Financial Group's portfolio in Q2 2026, its #87 holding.
  • Shum Financial Group first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • Shum Financial Group's Amgen position peaked at $352K in Q3 2024.
  • 1,943 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Shum Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.